Blog

Five ovarian cancer treatments are being reviewed by the National Institute for Health and Care Excellence (NICE) to ensure the ...

The agenda for the 19 November 2014 Transparency Commission meeting is now available.  The Commission will consider the following medicines: ...

Breast and lung cancer patients will have affordable access to life-changing medicines that normally cost up to $80,000 for treatment ...

Biogen Idec Canada announced today that Alberta Health will now reimburse Tecfidera (dimethyl fumarate) through the Alberta Drug Benefit List (DBL). Tecfidera is ...

Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one ...

24 February 2015 - British doctors called on Tuesday for Roche's cancer drug Avastin to be made routinely available as a ...

Biotie Therapies (Biotie) announces that the National Institute for Health and Care Excellence (NICE), the United Kingdom's health technology assessment ...

The flawed "nineteenth century" Australian health system is neglecting one third of Australians cancer patients. ...

[:content [\I \n \space \f \i \n \a \l \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \, \space \N \I \C \E \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \  \I \l \u \v \i \e \n \space \( \f \l \u \o \c \i \n \o \l \o \n \e \space \a \c \e \t \o \n \i \d \e \space \i \n \t \r \a \v \i \t \r \e \a \l \space \i \m \p \l \a \n \t \) \space \a \s \space \a \n \space \o \p \t \i \o \n \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \c \h \r \o \n \i \c \space \d \i \a \b \e \t \i \c " ..."]]

[:content [\O \u \r \space \e \x \p \a \n \d \i \n \g \space \k \n \o \w \l \e \d \g \e \space \o \f \space \t \h \e \space \m \o \l \e \c \u \l \a \r \space \b \i \o \l \o \g \y \space \o \f \space \m \a \l \i \g \n \a \n \c \y \, \t \h \e \space \r \e \l \a \t \e \d \space \i \d \e \n \t \i \f \i \c \a \t \i \o \n \space \o \f \space \t \h \e \r \a \p \e \u \t \i \c \a \l \l \y \- \i \m \p \o \r \t \a \n \t \space \t \a \r \g \e \t \s \, \a \n \d \space \t \h \e \space \s \u \b \s \e \q \u \e \n \t \space \d \e \v \e \l \o \p \m \e \n \t \space \o \f \space \s \y \s \t \e \m \i \c \space \a \g \e \n \t \s " ..."]]

The agenda for the 7 January 2015 Transparency Commission meeting is now available. The Commission will consider the following medicines: ...

Simprevir (trade name Olysio) has been available since May 2014 for the treatment of adults with chronic hepatitis C infection. The Institute for Quality and ...

NICE is recommending two new biosimilar versions of one of the world's biggest selling drugs and says that these new ...

[:content [\2 \4 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \T \h \e \space \A \u \s \t \r \a \l \i \a \n \space \G \o \v \e \r \n \m \e \n \t \space \p \r \o \v \i \d \e \s \space \a \s \s \i \s \t \a \n \c \e \space \w \i \t \h \space \t \h \e \space \c \o \s \t \space \o \f \space \p \r \e \s \c \r \i \p \t \i \o \n \space \p \h \a \r \m \a \c \e \u \t \i \c \a \l \s \space \t \h \r \o \u \g \h \space \t \h \e \space \P \B \S \space \a \n \d \space \t \h \e \space \L \S \D \P \. " ..."]]